10 Oversold Growth Stocks to Invest In Now

8. Biodesix, Inc. (NASDAQ:BDSX)

Number of Hedge Fund Holders: 6

Biodesix, Inc. (NASDAQ:BDSX) is one of the best oversold growth stocks to invest in now. Canaccord lifted the price target on Biodesix, Inc. (NASDAQ:BDSX) to $22 from $20 on May 5, reiterating a Buy rating on the shares. The firm stated that the price target increase is driven primarily by raised revenue assumptions and operating margin expansion in its 10-year DCF model.

The rating update came after Biodesix, Inc. (NASDAQ:BDSX) reported business and financial results for fiscal Q1 2026 on May 4, reporting that Diagnostic Testing revenue reached $22.3 million in the quarter, representing 37% year-over-year growth. This was attributed to a 29% increase in test volumes to 17,800 and a higher average revenue per test, while the improvement in average revenue per test was primarily driven by expanded payer coverage and enhancements to revenue cycle management.

Biodesix, Inc. (NASDAQ:BDSX) further reported that total revenue for fiscal Q1 2026 was $25.6 million, up 42% over the respective prior-year comparable period, with an 84% gross margin.

Biodesix, Inc. (NASDAQ:BDSX) is a provider of blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat and VeriStrat, along with six other diagnostic tests, including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test, and the Platelia SARS-CoV-2 test.